It is well known that type 2 diabetes and obesity are strongly associated. However, less is known about the mortality risk associated with elevated body weight in these patients vs the general population....
The authors of a new study evaluated the effects of prediabetes and diabetes vs normoglycemia on memory and various other cognitive measures in order to determine whether the presence of diabetes impacted...
In a recent study, researchers examined the effects of treatment with a particular diabetes drug on the risk of cardiovascular-related and all-cause mortality in patients with diabetes.
In a new study, researchers evaluated the safety and efficacy of a certain drug in the prevention of stroke recurrence among patients with ischemic stroke without diabetes.
Evidence has indicated that many older type 2 diabetes patients in the United States and Europe are overtreated for their condition. In a recent study, researchers investigated the level of personalized...
The authors of the PROCEED Study evaluated how a high- vs low-sodium diet, along with paricalcitrol treatment vs placebo, affects certain patients with type 2 diabetes.
In patients being treated for tuberculosis, the presence of type 2 diabetes is associated with worse outcomes. However, the effects of metformin use in this patient population are unknown.
Previous research has suggested that adults with diabetes have lower forced vital capacity than those without diabetes, but little data is available on the association between diabetes and restrictive lung...
Although diabetes is known to influence mortality and cognition, researchers have not yet ascertained how life expectancy with or without cognitive impairment is affected by diabetes in middle-aged and...
The US Food and Drug Administration has approved a new sodium-glucose co-transporter 2 (SGLT2) inhibitor for the improvement of glycemic control in adults with type 2 diabetes.
